Middle East & Africa Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)
The Middle East & Africa blood plasma derivatives market was valued at US$ 1,402.51 million in 2022 and is projected to reach US$ 2,223.69 million by 2028; it is expected to grow at a CAGR of 8.0% from 2022 to 2028.
Increasing Usage of Immunoglobulin G in Multiple Treatments is Driving the Middle East & Africa Blood Plasma Derivatives Market
Immunoglobulin G (IgG) therapies are highly used to treat primary immune deficiency cause by the genetics. The demand for IgG has been increasing steadily for the last few years due to the increasing awareness of IgG therapy. The growth is also accounted for its new therapy for its newly identified indication. Based on controlled trials done by Network Meta Analysis (NMA), IgG therapy has been approved for the treatment of Guillain-Barré syndrome (GBS), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Multifocal Motor Neuropathy (MMN), and dermatomyositis. The Immunoglobulin G (IgG) therapies is also effective for the treatment of myasthenia gravis exacerbations and stiff-person syndrome. In addition, it provides convincing efficacy in autoimmune disorders like epilepsy, neuromyelitis, and autoimmune encephalitis.
A large proportion of IgG is used in specialties outside of immunology, such as oncology, neurology, hematology, and rheumatology. Compared to all, neurology is the fastest-growing specialty in the global market. The growth of the Immunoglobulin G market is attributed due to its approved for on-label use for chronic inflammatory demyelinating polyneuropathy (CIDP) followed by its off-label use in secondary immune deficiencies caused by lymphoma, myeloma, and leukemia and the certain immunosuppressive therapies esp. B-cell targeting therapies. Thus the wide range of IgG usage in multiple treatments for on-label and off-label prescription will continue to expand and drive IgG demand across the global market in the coming years.
Middle East & Africa Blood Plasma Derivatives Market Overview
The Middle East & Africa blood plasma derivatives market has been segmented into the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. Saudi Arabia is expected to account for the largest market share and is expected to boost moderately in the Middle East & Africa. The region has a significant prevalence of hemophilia, von Willebrand disease, and other bleeding disorders, increasing the adoption of plasma derivatives products for treatment. Furthermore, various partnerships between the market players and the government are also boosting the adoption of plasma derivatives for treatment boosting the market growth. For instance, in October 2021, Grifols and National Service Projects Organization (NSPO) Egypt inaugurated the first African plasma-supply platform, in Cairo, as part of the alliance to attain self-sufficiency in plasma-derived medicines. This will enhance access to plasma products in the Middle East, Africa, and other countries boosting the market growth.
Middle East & Africa Blood plasma derivatives Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Blood plasma derivatives Market Segmentation
The Middle East & Africa blood plasma derivatives market is segmented into type, application, end user, and country.
The Middle East & Africa blood plasma derivatives market, by type, is segmented into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. The immunoglobulins segment held a larger market share in 2022.
Based on application, the Middle East & Africa blood plasma derivatives market is divided into hemophilia, hypogammaglobulinemia, immunodeficiency diseases, von Willebrand disease, and other applications. The immunodeficiency diseases applications segment held the largest share of the market in 2022.
The blood plasma derivatives market, by end user, is segmented into hospitals, diagnostic laboratories, clinics, and other end users. The hospitals segment held the largest share of the market in 2022.
Based on country, the Middle East & Africa blood plasma derivatives market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the market in 2022.
Grifols SA; SK Plasma Co Ltd; Octapharma AG; Monobind Inc.; Intas Pharmaceuticals Ltd; CSL Behring LLC; LFB SA; Kedrion SpA; and Fusion Health Care Pvt Ltd are the leading companies operating in the Middle East & Africa blood plasma derivatives market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Blood Plasma Derivatives Market – by Type
1.3.2 Middle East & Africa Blood Plasma Derivatives Market – by Application
1.3.3 Middle East & Africa Blood Plasma Derivatives Market – by End User
1.3.4 Middle East & Africa Blood Plasma Derivatives Market – by Country
2. Middle East & Africa Blood Plasma Derivatives Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Blood Plasma Derivatives Market – Market Landscape
4.1 Overview
4.2 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. Middle East & Africa Blood Plasma Derivatives Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of Blood Disorders
5.1.2 Rise in Geriatric Population
5.2 Market Restraints
5.2.1 Complicated Reimbursement Policies
5.3 Market Opportunities
5.3.1 Incorporation of Platelet-Rich Plasma in Regenerative Medicine
5.4 Future Trends
5.4.1 Increasing Usage of Immunoglobulin G in Multiple Treatments
5.5 Impact Analysis
6. Blood Plasma Derivatives Market – Middle East & Africa Analysis
6.1 Middle East & Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7. Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – by Type
7.1 Overview
7.2 Middle East & Africa Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Albumin
7.3.1 Overview
7.3.2 Albumin: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Factor VIII
7.4.1 Overview
7.4.2 Factor VIII: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Factor IX
7.5.1 Overview
7.5.2 Factor IX: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Immunoglobulin
7.6.1 Overview
7.6.2 Immunoglobulin: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.3 IgG
7.6.3.1 Overview
7.6.3.2 IgG: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.4 IgM
7.6.4.1 Overview
7.6.4.2 IgM: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.5 IgA
7.6.5.1 Overview
7.6.5.2 IgA: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.6 IgD
7.6.6.1 Overview
7.6.6.2 IgD: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.7 IgE
7.6.7.1 Overview
7.6.7.2 IgE: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Hyperimmune Globulin
7.7.1 Overview
7.7.2 Hyperimmune Globulin: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Blood Plasma Derivatives Market Analysis and Forecasts to 2028 – by Application
8.1 Overview
8.2 Middle East & Africa Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)
8.3 Hemophilia
8.3.1 Overview
8.3.2 Hemophilia: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hypogammaglobulinemia
8.4.1 Overview
8.4.2 Hypogammaglobulinemia: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Immunodeficiency Diseases
8.5.1 Overview
8.5.2 Immunodeficiency Diseases: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Von Willebrand Disease
8.6.1 Overview
8.6.2 Von Willebrand Disease: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Other Applications
8.7.1 Overview
8.7.2 Other Applications: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – by End User
9.1 Overview
9.2 Middle East & Africa Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Other End Users
9.5.1 Overview
9.5.2 Other End Users: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10. Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – Country Analysis
10.1 Overview
10.1.1.1 UAE: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 UAE: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 UAE: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.1.3.1 UAE: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.1.4 UAE: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.1.5 UAE Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.1.2 Saudi Arabia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Saudi Arabia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Saudi Arabia: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.2.3.1 Saudi Arabia: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.2.4 Saudi Arabia: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.2.5 Saudi Arabia Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.1.3 South Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 South Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 South Africa: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.3.3.1 South Africa: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.3.4 South Africa: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.3.5 South Africa Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.1.4 Rest of Middle East & Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.4.3.1 Rest of Middle East: Blood Plasma Derivatives Market, by immunoglobulin, 2019–2028 (US$ Million)
10.1.1.4.4 Rest of Middle East & Africa: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.4.5 Rest of Middle East & Africa Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Blood Plasma Derivatives Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Grifols SA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 SK Plasma Co Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Octapharma AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Monobind Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Intas Pharmaceuticals Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Fusion Health Care Pvt Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 CSL Behring LLC
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 LFB SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Kedrion SpA
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. UAE Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. UAE Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 3. UAE Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. UAE Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. Saudi Arabia Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. Saudi Arabia Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 7. Saudi Arabia Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. Saudi Arabia Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. South Africa Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. South Africa Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 11. South Africa Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. South Africa Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of Middle East & Africa Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Rest of Middle East Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 15. Rest of Middle East & Africa Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of Middle East & Africa Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Recent Inorganic Growth Strategies in the Blood Plasma Derivatives Market
Table 18. Recent Organic Growth Strategies in the Blood Plasma Derivatives Market
Table 19. Glossary of Terms
LIST OF FIGURES
Figure 1. Middle East & Africa Blood Plasma Derivatives Market Segmentation
Figure 2. Middle East & Africa Blood Plasma Derivatives Market, by Country
Figure 3. Middle East & Africa Blood Plasma Derivatives Market Overview
Figure 4. Immunoglobulin Segment Held Largest Share of Type Segment in Middle East & Africa Blood Plasma Derivatives Market
Figure 5. UAE is Expected to Show Remarkable Growth During Forecast Period
Figure 6. Middle East & Africa: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Middle East & Africa Blood Plasma Derivatives Market: Impact Analysis of Drivers and Restraints
Figure 9. Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Middle East & Africa Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)
Figure 11. Albumin: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Factor VIII: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Factor IX: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Immunoglobulin: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. IgG: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. IgM: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. IgA: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. IgD: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. IgE: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Hyperimmune Globulin: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Middle East & Africa Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)
Figure 23. Hemophilia: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Hypogammaglobulinemia: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Immunodeficiency Diseases: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Von Willebrand Disease: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other Applications: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Middle East & Africa Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)
Figure 29. Hospitals: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Clinics: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Other End Users: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Middle East & Africa: Blood Plasma Derivatives Market, by Key Country – Revenue (2021) (US$ Million)
Figure 33. Middle East & Africa: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)
Figure 34. UAE: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Saudi Arabia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. South Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Rest of Middle East & Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Growth Strategies in the Blood Plasma Derivatives Market
- Grifols SA
- SK Plasma Co Ltd
- Octapharma AG
- Monobind Inc.
- Intas Pharmaceuticals Ltd
- CSL Behring LLC
- LFB SA
- Kedrion SpA
- Fusion Health Care Pvt Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa blood plasma derivatives market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa blood plasma derivatives market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the blood plasma derivatives market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution